Single tube, six-color flow cytometric analysis is a sensitive and cost-effective technique for assaying clonal plasma cells

American Journal of Clinical Pathology

Volumn 133, Issue 5, 2010, Pages 694-699

  Marsee, Derek K ^a   Li, Betty ^a   Dorfman, David M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Flow cytometry; Multiple myeloma; Plasma cell myeloma

Indexed keywords

ADULT; ANALYTIC METHOD; ARTICLE; BONE MARROW; CANCER PATIENT; CELL CLONE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; BONE MARROW CELL; COST BENEFIT ANALYSIS; ECONOMICS; IMMUNOLOGY; INSTRUMENTATION; METHODOLOGY; PATHOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY;

BONE MARROW CELLS; CLONE CELLS; COST-BENEFIT ANALYSIS; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MULTIPLE MYELOMA; PLASMA CELLS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 77951935827     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPKKNPMLWX9ZXB     Document Type: Article

References (10)

1. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121:749-757.
2. McKenna RW, Kyle RA, Kuehl WM, et al. Plasma cell neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008:200-213.
3. Richardson PG, Mitsiades C, Schlossman R, et al. New drugs for myeloma. Oncologist. 2007;12:664-689.
4. Rawstron AC. Immunophenotyping of plasma cells. Curr Protoc Cytom. 2006;chapter 6:unit 6.23.
5. Lin P, Owens R, Tricot G, et al. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am J Clin Pathol. 2004;121:482-488.
6. Morice WG, Hanson CA, Kumar S, et al. Novel multi-parameter flow cytometry sensitively detects phenotypically distinct plasma cell subsets in plasma cell proliferative disorders. Leukemia. 2007;21:2043-2046.
7. de Tute RM, Jack AS, Child JA, et al. A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma. Leukemia. 2007;21:2046-2049.
8. Cao W, Goolsby CL, Nelson BP, et al. Instability of immunophenotype in plasma cell myeloma. Am J Clin Pathol. 2008;129:926-933.
9. Paiva B, Vidriales MB, Cervero J, et al. Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation. Blood. 2008;112:4017-4023.
10. Rawstron AC, Orfao A, Beksac M, et al. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica. 2008;93:431-438.